Could a simple vitamin cut Post-Transplant infections?
NCT ID NCT06736093
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This trial asks whether giving vitamin D3 to people with low vitamin D before a liver transplant can reduce bacterial infections in the first three months after surgery. Adults with cirrhosis and vitamin D deficiency who are scheduled for a liver transplant will receive either weekly vitamin D3 or a placebo for at least six weeks before the transplant. Researchers will compare infection rates, rejection episodes, and sepsis between the two groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Vitamin D3 (cholecalciferol) 60,000 IU taken once weekly before liver transplant
- What this could lead to
- If effective, giving vitamin D before a liver transplant could reduce post-transplant infections and improve recovery.
- What could go wrong
- This is a single-center trial, and results may not apply broadly. Vitamin D may not change infection rates, and high doses could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS OF LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.